AMENDMENT NO. 2 TOConsulting and Intellectual Property Agreement • February 22nd, 2013 • Intercept Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Amendment No. 2 to Consulting and Intellectual Property (“IP”) Agreement (this “Amendment”), dated February 15, 2013, is entered into by and between INTERCEPT PHARMACEUTICALS, INC., a corporation organized and existing under the laws of Delaware, with its registered office at 18 Desbrosses Street, New York, NY 10013, USA (“INTERCEPT”) on the one hand and ROBERTO PELLICCIARI (“Consultant”), residing at Via U. Rocchi, 60, Perugia, Italy 06123, on the other hand:
CONSULTING AND INTELLECTUAL PROPERTY (“IP”) AGREEMENTConsulting and Intellectual Property Agreement • September 27th, 2012 • Intercept Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Consulting and IP Agreement (this “Agreement”) is effective as of August 1, 2011, (the “Effective Date”) and is entered into by and between INTERCEPT PHARMACEUTICALS, INC., a corporation organized and existing under the laws of Delaware, with registered office at 18 Desbrosses Street, New-York 10013 NY, USA (“INTERCEPT”) on the one hand and ROBERTO PELLICCIARI (“Consultant”), residing at Via U. Rocchi, 60, Perugia, Italy 06123, on the other hand.
CONSULTING AND INTELLECTUAL PROPERTY (“IP”) AGREEMENTConsulting and Intellectual Property Agreement • September 4th, 2012 • Intercept Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Consulting and IP Agreement (this “Agreement”) is effective as of August 1, 2011, (the “Effective Date”) and is entered into by and between INTERCEPT PHARMACEUTICALS, INC., a corporation organized and existing under the laws of Delaware, with registered office at 18 Desbrosses Street, New-York 10013 NY, USA (“INTERCEPT”) on the one hand and ROBERTO PELLICCIARI (“Consultant”), residing at Via U. Rocchi, 60, Perugia, Italy 06123, on the other hand.
OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION CONFIDENTIAL TREATMENT REQUESTED UNDER 17 C.F.R. SECTION 240.24b-2 AMENDMENT NO. 4 TO CONSULTING AND INTELLECTUAL PROPERTY (“IP”) AGREEMENTConsulting and Intellectual Property Agreement • January 2nd, 2014 • Intercept Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Amendment No. 4 to Consulting and Intellectual Property (“IP”) Agreement (this “Amendment”), dated November 5, 2013, is entered into by and between INTERCEPT PHARMACEUTICALS, INC., a corporation organized and existing under the laws of Delaware, with its registered office at 18 Desbrosses Street, New York, NY 10013, USA (“INTERCEPT”), on the one hand and ROBERTO PELLICCIARI (“Consultant”), residing at Via U. Rocchi, 60, Perugia, Italy 06123, on the other hand:
AMENDMENT N°1 TOConsulting and Intellectual Property Agreement • September 4th, 2012 • Intercept Pharmaceuticals Inc • Pharmaceutical preparations
By and between INTERCEPT PHARMACEUTICALS, INC., a corporation organized and existing under the laws of Delaware, with registered office at 18 Desbrosses Street, New-York 10013 NY, USA (“INTERCEPT”) on the one hand and ROBERTO PELLICCIARI (“Consultant”), residing at Via U. Rocchi, 60, Perugia, Italy 06123, on the other hand:
